When multiple actionable alterations are detected, most ACC MTBs prioritize by ad hoc literature search, with a clear trend to use target therapy before checkpoint blockade, and extreme caution in considering off-label combinations (Additional file 1 : Appendix I).
← all excerpts
Bridging therapeutic opportunities: a survey by the Italian molecular tumor board workgroup of Alliance Against Cancer.
1
—
—